You just read:

HETLIOZ® Receives European Commission Approval for the Treatment of Non-24-Hour Sleep-Wake Disorder in the Totally Blind

News provided by

Vanda Pharmaceuticals Inc.

Jul 07, 2015, 04:30 ET